Mice treated with IL-10R-blocking antibodies had a significantly lower mean peak parasitemia (2.77% ± 2.77%) than mice in the rat Ig control group and all other groups; however, they had high clinical scores on day 6 post-challenge infection, and 60% succumbed to the infection (Fig. 7C). Here, IL10RA is linked to parasitic infectious disease.